Business Description
Bio-Works Technologies AB
ISIN : SE0007387089
Total Employee Number:
33Compare
Compare
Traded in other countries / regions
BIOWKS.Sweden1BD.Germany IPO Date
2017-12-14Description
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.78 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 14.28 | |||||
Beneish M-Score | -1.28 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.8 | |||||
3-Year EBITDA Growth Rate | 41.3 | |||||
3-Year EPS without NRI Growth Rate | 42.9 | |||||
3-Year FCF Growth Rate | 37 | |||||
3-Year Book Growth Rate | -28.5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.06 | |||||
9-Day RSI | 57.18 | |||||
14-Day RSI | 52.69 | |||||
3-1 Month Momentum % | -5.44 | |||||
6-1 Month Momentum % | 16.61 | |||||
12-1 Month Momentum % | 20.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.44 | |||||
Quick Ratio | 3.46 | |||||
Cash Ratio | 2.66 | |||||
Days Inventory | 244.97 | |||||
Days Sales Outstanding | 37.69 | |||||
Days Payable | 65.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.8 | |||||
Shareholder Yield % | -6.68 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 75 | |||||
Operating Margin % | -6.65 | |||||
Net Margin % | -3.13 | |||||
EBITDA Margin % | -6.04 | |||||
FCF Margin % | -11.11 | |||||
OCF Margin % | -10.98 | |||||
ROE % | -6.47 | |||||
ROA % | -4.32 | |||||
ROIC % | -12.53 | |||||
3-Year ROIIC % | 255.04 | |||||
ROC (Joel Greenblatt) % | -105.44 | |||||
ROCE % | -13.73 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 5.3 | |||||
PS Ratio | 3.93 | |||||
PB Ratio | 6.16 | |||||
Price-to-Tangible-Book | 6.18 | |||||
EV-to-EBIT | -54.47 | |||||
EV-to-EBITDA | -60 | |||||
EV-to-Revenue | 3.62 | |||||
EV-to-Forward-Revenue | 2.69 | |||||
EV-to-FCF | -30.44 | |||||
Price-to-GF-Value | 0.94 | |||||
| Price-to-Net-Current-Asset-Value | 6.3 | |||||
| Price-to-Net-Cash | 13.08 | |||||
Earnings Yield (Greenblatt) % | -1.84 | |||||
FCF Yield % | -2.69 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio-Works Technologies AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 82.847 | ||
| EPS (TTM) (kr) | -0.06 | ||
| Beta | 0.9991 | ||
| 3-Year Sharpe Ratio | -0.1 | ||
| 3-Year Sortino Ratio | -0.15 | ||
| Volatility % | 82.18 | ||
| 14-Day RSI | 52.69 | ||
| 14-Day ATR (kr) | 0.254861 | ||
| 20-Day SMA (kr) | 3.345 | ||
| 12-1 Month Momentum % | 20.07 | ||
| 52-Week Range (kr) | 2.03 - 4.98 | ||
| Shares Outstanding (Mil) | 100.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio-Works Technologies AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio-Works Technologies AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-19 | In 182 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 77 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | 3.38 (+5.62%) | ||
| General meeting for 2026 | 2026-06-04 09:00 | 3.92 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 3.15 (+2.94%) | ||
| Annual report for 2025 | 2026-04-17 | 3.30 (-0.30%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-20 | 3.08 (+0.65%) | ||
| Third quarter earnings results for 2025 | 2025-11-07 | 2.42 (-3.20%) | ||
| Second quarter earnings results for 2025 | 2025-08-15 | 2.61 (-0.38%) | ||
| General meeting for 2025 | 2025-05-15 09:00 | 1.28 (+6.67%) |
Show
Entries
Bio-Works Technologies AB Frequently Asked Questions
What is Bio-Works Technologies AB(XSAT:BIOWKS)'s stock price today?
The current price of XSAT:BIOWKS is kr3.40. The 52 week high of XSAT:BIOWKS is kr4.98 and 52 week low is kr2.03.
When is next earnings date of Bio-Works Technologies AB(XSAT:BIOWKS)?
The next earnings date of Bio-Works Technologies AB(XSAT:BIOWKS) is 2026-08-21.
Does Bio-Works Technologies AB(XSAT:BIOWKS) pay dividends? If so, how much?
Bio-Works Technologies AB(XSAT:BIOWKS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bio-Works Technologies AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers